Recent Headlines
Within Medical Laboratories & Research

Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting

Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be... - May 22, 2018 - Perthera, Inc.

Mercodia Launches Unique Quality System

The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB

$3.7M Research Grant Awarded to Artificial Intelligence Project for Medical Imaging

University of Waterloo’s Kimia receives $3.7M for its AI project for digital pathology. - May 16, 2018 - Kimia Lab, University of Waterloo

Wellness Family Medicine RN, Betty Abernathy, Approved with Aetna

Wellness Family Medicine Registered Nurse, Betty Abernathy, has been approved with Aetna. "Aetna health insurance products include medical, pharmacy, dental, behavioral health, group life and disability plans." (https://www.aetna.com/about-us/aetna-facts-and-subsidiaries.html) Betty has... - May 10, 2018 - Wellness Family Medicine

Betty Abernathy, RN at Wellness Family Medicine, Now Accepts First Choice by Select Health of South Carolina

Patients who are insured by First Choice by Select Health of South Carolina can now be seen by registered nurse Betty Abernathy. - May 09, 2018 - Wellness Family Medicine

Apostle Inc Announces Acceptance Into the StartX Accelerator Program

Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc

EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines

EpicentRx, a San Diego biotechnology company developing a next-generation immunotherapy platform of viruses that infect and kill cancer cells for the treatment of several tumor types, has developed the first ever series of oncolytic viruses tailored to tumors of individual patients. The first... - May 03, 2018 - EpicentRx, INC

Oxipit’s Chest X-Ray Search Solution Selected as One of Top Innovations by SIIM

Oxipit’s ChestGlass has been selected as one of the top projects for the 2018 Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge. ChestGlass is the first-to-market chest X-ray search solution that allows to find radiologically similar images in a given database. - April 27, 2018 - Oxipit

New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis

Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company

Assisted Reproductive Technology / In Vitro Fertilization (ART / IVF) Success is Lower in Young Women; Its Decline Begins Earlier Than Thought, Occurs at Increasing Rates

Previously, it was assumed that ART/IVF success in women using their fresh embryos remains stable until mid-30s before it begins to decline. But a new study of CDC data with almost half a million cycles disproves this and shows success is lower also in very young women, up to age 28, and declining thereafter. Age-driven decline begins earlier than at previously thought mid-30s and occurs at increasing rates. Infertile women older than 30 should not delay ART/IVF treatment, if it is their option. - April 13, 2018 - Stats of the ART

Cyrus Diagnostic Imaging Now Offers Enhanced Patient Comfort and Power in MRI Exams

The accommodating features of the MAGNETOM Skyra, combined with 3 Tesla (T) magnet strength – the strongest clinically available– means that Cyrus Diagnostic Imaging patients can now enjoy a larger array of imaging options with high quality images. - April 11, 2018 - Cyrus Diagnostic Imaging

Apostle Inc Announces Joint Venture with Southern University of Science and Technology in the Greater China Region

Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle... - April 04, 2018 - Apostle Inc

Betty Abernathy, FNP, MSN, Approved with TRICARE

Wellness Family Medicine in Spartanburg, South Carolina is happy to announce that as of March 25, 2018 Registered Nurse, Betty Abernathy, is now in network with TRICARE insurance. - March 31, 2018 - Wellness Family Medicine

The Outdoor Sports Season is Underway: ASAlaser's Therapies Provide Valuable Assistance in Treating Foot Issues

MLS® and Hilterapia® prove to be successful in enabling runners and bikers to resume sports activities after forced stops due to painful issues of the ankle-foot-heel. - March 24, 2018 - ASA srl

NCHQA's Choosing Wisely® in NC Program Significantly Reduces Unnecessary Medical Tests and Antibiotic Overuse

The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA

ClinSearch Announces Transition in Leadership Team Welcomes Mark M. McKenzie, M.D. as Medical Director

ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the... - March 10, 2018 - Wake Research Associates

Atlanta Center for Medical Research Selected for Award

Georgia Bio honors ACMR with a Georgia Bio Community Award. - March 03, 2018 - Atlanta Center for Medical Research

Clear Scientific Announces New Aspergillus Testing Product for Booming Cannabis Industry

Laboratory Development and Supply Company, Clear Scientific expands their scientific cannabis product line. - March 01, 2018 - Clear Scientific

Ostium Launch a Crowdfunding Campaign with IndieGoGo

Ostium makes it possible to detect illnesses at the stage of early functional disruptions, long before the onset of the first noticeable symptoms. Moreover, Ostium are able to predict, well in advance, many serious ailments, from asthma to tumors. Ostium Lab launch a crowdfunding campaign with IndieGoGo to continue their project, to improve the hardware and software complex, to process state registration and to launch mass production. - February 26, 2018 - Ostium

MCS System NGDS-1 Program Announced as a Finalist in the Medical/Dental Category for the 2018 Edison Awards

The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) Next Generation Diagnostic System Increment 1 (NGDS Inc 1) program has been named a finalist in the Medical/Dental category for the 2018 Edison Awards. Established in 1987 and often described as “the Oscars of... - February 26, 2018 - JPM-MCS

Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies

Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd

Medical Evolutions 1 Inc. Rolls Out Direct to Consumer Comprehensive Pharmacogenomic Testing

Medical Evolutions 1 Inc. was established to educate the general public on becoming “empowered” in participating in their own healthcare along with their physician via the Medical Evolutions 1 Inc. Pharmacogenomic Comprehensive ME TEST™. The goal is to make the ordering and utilization of the test a simple, uncomplicated yet an effective process as well as making the test economically available to most. - February 21, 2018 - Medical Evolutions 1 Inc.

Perthera Inc. and Blue Faery Announce Their Partnership Against Liver Cancer

Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual... - February 20, 2018 - Perthera, Inc.

Apostle Inc Appoints Alexander Hartemink, PhD at Duke University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the... - February 19, 2018 - Apostle Inc

ASAlaser 2017: Double-Digit Growth of Turnover and Staff

Turnover has increased by 13% compared with 2016, staff has increased by 20%, 14% of investment in research and the launch of a new therapeutic solution: these are the figures of the year which has just ended for the company that has made laser therapy its flagship of excellence. The 2018 objective? Growth marked by internationalisation. - February 17, 2018 - ASA srl

Gordon Early, Wellness Family Medicine, Approved with TRICARE

Wellness Family Medicine in Spartanburg, South Carolina has been approved to accept TRICARE insurance. - February 13, 2018 - Wellness Family Medicine

Apostle Inc Appoints David B. Goldstein, PhD at Columbia University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc

Oxford Optronix Ltd. and Scintica Instrumentation Inc. Proudly Announce Agreement on Official Product Distribution for North America

With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix. The Scintica team consists of... - February 07, 2018 - Scintica Instrumentation

ReproTech, Ltd. Announces Collaboration with Fertility Preservation Trust

Latest innovation in cryostorage planning expand options for reproductive tissue disposition. - February 01, 2018 - ReproTech, LLC

Mopec Announces Addition of New Board Members

Mopec, an industry leading manufacturer and distributor of high quality pathology, anatomy, mortuary, and necropsy equipment and products, is pleased to announce the addition of Sally Brandtneris and Dr. Joyce deJong to the Company’s Board of Directors. - January 31, 2018 - Mopec

NanoHybrids Launches Revolutionary Contrast Agent to Measure EPR Effect at 2018 SPIE BiOS Expo

NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids

Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.

Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration

Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates

European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human... - January 15, 2018 - Endoceutics

Research Square Announces Engaging New Multimedia Product, Video Bytes, to Share Research Results with the Public

Video Bytes are 1-minute summaries of published research that help scientists convey the importance of their work to the public. - January 12, 2018 - Research Square

A New Technique That Corrects Myopia (Nearsightedness) Has Been Developed by Dr. Antonio Medina at MIT and Several Medical Institutions Across the World

A patient’s cornea can be altered in a simple manner designed to correct myopia and other refractive errors. The Nature Journal Eye published in print the complete article by Antonio Medina as well as supplemental files that will aid those interested in using this new technology. The article is featured on the cover of the issue and titled, Plastic modification of the cornea by pneumatic force corrects myopia: Pneumatic Keratology Eye (2017) 31, 1621–1627 - December 31, 2017 - Antonio Medina

SARI Announced It Has Entered Into an Agreement to Acquire the 90% Interests in NMS Group

SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group

Internationally Renowned Tech Innovators and Investors Are Flocking to Cork for Beyond the Internet of Things Ground-Breaking Event Sponsored by SteriTrack Ltd

A new year and a new event looking beyond the new – Nimbus Research Centre, in collaboration with SteriTrack, are proud to host a ground-breaking event for 2018 “Beyond the Internet of Things – How to harness the next wave of digital technology and investment” at... - December 26, 2017 - Matrix Medical Tracking Systems

NanoHybrids Inc. Awarded NIH Grant to Advance Nanoparticle Enabled Photodynamic Therapy for Oral Cancer

NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids

Targeted Hyperthermia Treatment Accepted for Full Characterization at the Frederick National Laboratory for Cancer Research

Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids

Qualitative Identification of Synthetic Cannabinoids Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF/MS)

A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent... - December 14, 2017 - Cayman Chemical Company

International Society on Thrombosis and Haemostasis Selects City of London as 2022 Congress Location

The International Society on Thrombosis and Haemostasis (ISTH) today announced that the city of London has been selected as the location for the ISTH 2022 Congress. The official meeting dates will be announced in early 2018. “On behalf of the thrombosis and haemostasis community in the... - December 13, 2017 - International Society on Thrombosis and Haemostasis (ISTH)

Blue Diesel Data Science Introduces Pharmaceutical Insight Platform Reducing Research Time from Weeks to Minutes

Blue Diesel Data Science announces the beta launch of its pharmaceutical platform VisionaryRX. VisionaryRX provides a deep and comprehensive view into the drug industry. It relates multiple forms of industry standard data in the pharmaceutical industry under one view. Because VisionaryRX uses over 50 million rows of information, the result is fast and complete visibility into the industry. Useful for pharmaceutical manufacturing, labeling, partnerships and strategic direction insight. - December 10, 2017 - Blue Diesel Data Science

GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)

GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.

Analyte Health Expands Market Leadership, Launches Health Test Express Brand

Health Test Express Makes At-Home Health Testing Available - December 02, 2017 - Analyte Health

Perthera and ZERO Announce the Decode Your Prostate Cancer Program

Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with... - November 28, 2017 - Perthera, Inc.

Mopec Creates Cadaver Lifts with Adaptable, Clear Design That Exceeds Industry Standards

Mopec introduces new cadaver lift series that feature more versatility in design and performance. Created with the consumer in mind, each lift has an adjustable top with a simple structure, achieving a Mopec standard in efficiency. An enhanced mechanical system offers advanced technological... - November 24, 2017 - Mopec

Recent Headlines Within Medical Laboratories & Research

Recent Headlines
Within Medical Laboratories & Research